Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Growth Large Cap
  • Asset Class: Equity
  • Geographic Focus: U.S.

Columbia Select Large Cap Growth Fund

+ Add to Watchlist

ELGCX:US

17.51 USD 0.08 0.46%

As of 09:29:30 ET on 03/30/2015.

Snapshot for Columbia Select Large Cap Growth Fund (ELGCX)

Year To Date: +6.57% 3-Month: +5.93% 3-Year: +15.96% 52-Week Range: 14.24 - 17.94
1-Month: -0.62% 1-Year: +15.83% 5-Year: +15.92% Beta vs RLG: 1.14

Mutual Fund Chart for ELGCX

No chart data available.
  • ELGCX:US 17.51
  • 1M
  • 1Y
Interactive ELGCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ELGCX

Columbia Select Large Cap Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is superior, long-term capital appreciation. The Fund invests at least 80% of its net assets in common stocks of large U.S. companies that have market capitalizations of companies included in the Russell 1000 Growth Index.

Inception Date: 09-28-2007 Telephone: 1-800-345-6611
Managers: THOMAS M GALVIN / RICHARD A CARTER
Web Site: www.columbiafunds.com

Fundamentals for ELGCX

NAV (on 2015-03-30) 17.51
Assets (M) (on 2015-03-27) 7,140.99
Fund Leveraged N
Minimum Investment 2,000.00
Minimum Subsequent Investment 0.00

Dividends for ELGCX

No dividends reported

Fees & Expenses for ELGCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.59
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 1.85

Top Fund Holdings for ELGCX

Filing Date: 01/30/2015
Name Position Value % of Total
Pharmacyclics Inc 1,991,397 336,048,244 4.942%
Amazon.com Inc 879,098 311,666,614 4.583%
LinkedIn Corp 1,362,056 306,108,465 4.501%
Biogen Inc 765,452 297,883,300 4.380%
Priceline Group Inc/The 291,427 294,189,728 4.326%
Illumina Inc 1,477,873 288,466,031 4.242%
Celgene Corp 2,338,942 278,708,329 4.098%
Visa Inc 3,900,376 248,561,212 3.655%
Vertex Pharmaceuticals Inc 2,227,395 245,325,285 3.608%
Bristol-Myers Squibb Co 4,051,733 244,197,948 3.591%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil